Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -28,846
▼ 51% vs 2024
Profit
Caution€ -179,928
▼ 122% vs 2024
Debts
Normal€ 5.7 million
▲ 188% vs 2024
DOLLIMMO BELGIUM from Nivelles, company number BE0765300009, closed financial year 2025 with a result of € -179,928 after tax. For that financial year DOLLIMMO BELGIUM recorded a gross margin of € -28,846 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € -81,025 to € -179,928. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
What happened at DOLLIMMO BELGIUM?
What happened at DOLLIMMO BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 179,928. Source: NBB ↗
- ADFINITIS SRL became a director. NBB
- Martial DOLLINGER stepped down as director. NBB
- NEXTGEN INVEST SRL became a director. NBB
- Claire BECKER stepped down as director. NBB
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
- Claire BECKER became a director. NBB
In short
From € 34,188 loss in 2021 to € 179,928 loss in 2025.
A new publication or filing at DOLLIMMO BELGIUM? We notify you, reason included.
Follow DOLLIMMO BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind DOLLIMMO BELGIUM are ADFINITIS SRL and NEXTGEN INVEST SRL. The same people are also behind DOLFINANCE and PHARMA FLEX.
Directors
According to the 2025 annual accounts
since 2024
since 2024
since 2021 · until 2024
Claire BECKER
Director
since 2021 · until 2024
Establishments
Establishment units
Physical locations of this company
Rue Graham Bell 8
1402 Nivelles
Dolezlaan 480
1180 Ukkel
Active since 17 March 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
PHARMA TECHNOLOGY
€ 26.8 million revenue · 2025
DOLFINANCE same network
€ 116,272 gross margin · 2025
PHARMA VAT UNIT
PHARMA FLEX same network
€ 2.1 million revenue · 2025
NextGen Invest same network
€ 123,127 gross margin · 2025
+1 more
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
IPV1-SIA-AS, LV
Website info
Features
Security
Details
- Company number
- 0765.300.009
- VAT number
- BE 0765.300.009
- Registered office
- Rue Graham Bell 8, 1402 Nivelles
- Names & denominations
- DOLLIMMO BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 March 2021
- Peppol
- Active · Active since 27 Mar 2026
- Contact
- pharmatec.be